Overview of Science Friday — “People are microdosing GLP-1s for weight loss. Is it safe?”
This episode examines the growing trend of “microdosing” GLP-1 weight-loss drugs like Ozempic, Wegovy, and Zepbound—often through telehealth companies and compounded pharmacies. Experts explain that while some people report good results on very small doses, there is currently little scientific evidence to support microdosing as a proven or standardized approach, especially outside FDA-approved dosing and formulations. The discussion emphasizes uncertainty around efficacy, safety, ingredient consistency, and the quality of follow-up care.
Key Takeaways
-
“Microdosing” GLP-1s has no standard clinical definition.
- Doctors described it as a dose below the lowest FDA-approved dose.
- There is no consensus yet on what exact dose counts as a microdose.
-
There is not enough research to recommend microdosing.
- The experts agreed that data on safety and effectiveness are lacking at sub-approved doses.
- Some patients may do well on low doses, but that does not establish a general rule.
-
Compounded versions are a major part of the trend.
- Many microdosing products are made by compounding pharmacies, especially during shortages.
- Compounded drugs can be useful when customization is needed, but they are not the same as FDA-approved products and are not tested through the same clinical trial process.
-
Marketing and access are driving adoption.
- Telehealth and social media marketing make these drugs easy to obtain.
- Experts worry that ads often emphasize benefits while downplaying risks.
Safety and Efficacy Concerns
What we know
- FDA-approved GLP-1s have gone through phase 1, 2, and 3 trials.
- Those studies established dosing, side effects, and expected responses.
What we don’t know
- Whether doses below the approved range work reliably.
- How safe these lower doses are over time.
- How they affect people who do not meet obesity/diabetes criteria.
- Whether adding ingredients like B12 or other vitamins changes how the drug behaves in the body.
Why compounded products raise concern
- Compounded medications may vary in:
- purity
- ingredients
- dosing consistency
- delivery devices/syringes
- Even if a compounded product is legal and state-regulated, it may still be less predictable than the branded drug.
What the Experts Said
On effectiveness
- Some patients on the lowest approved dose have lost significant weight and improved metabolic markers.
- But experts stressed that individual success stories do not equal evidence.
On safety
- The main concern is not just classic side effects, but the possibility of:
- unexpected reactions
- added ingredients causing unknown interactions
- inconsistent dosing from different compounders
On compounding pharmacies
- Compounding itself is a legitimate and valuable pharmacy practice.
- The problem arises when compounding is used at scale to mimic manufactured drugs without equivalent testing.
- The experts warned that some telehealth companies may obscure which pharmacy is actually filling the prescription.
Patient Experience and Real-World Issues
- Multiple callers reported positive experiences with microdosing or compounded semaglutide.
- One listener said they used an online telehealth company and adjusted doses themselves with success.
- Another reported losing nearly 30 pounds in 12 weeks using compounded semaglutide mixed with B12.
- The episode notes that these stories are common—but still anecdotal, not proof.
Practical Recommendations
For patients
- Ask who is prescribing and who is dispensing the medication.
- Make sure you know:
- what pharmacy is filling it
- what ingredients are included
- how to measure the dose correctly
- who to contact if side effects occur
- Tell your regular doctor if you are using a compounded GLP-1, even if you got it from a med spa or telehealth service.
- Don’t rely on year-long follow-up; these medications require closer monitoring.
For clinicians
- Follow patients closely and provide a clear follow-up plan.
- Be cautious about recommending microdosing without evidence.
- Consider the possibility of undisclosed compounded formulations or added ingredients.
Bottom Line
Microdosing GLP-1s is popular, but the episode’s core message is caution: there is not enough evidence to say it is reliably safe or effective. While some people may benefit, the practice often relies on compounded products and marketing that outpace the science. The experts call for more research, better oversight, and more transparent patient-provider communication.